logo

For the Inventor, By the Inventor

Saint Genis Laval, France

Daniel Guerrier

This inventor holds 16 USPTO granted patents and 2 published patent applications and 3 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Merck Patent Gmbh, Merck Patent Gesellschaft MIT Beschrankter Haftung, Lipha, Lyonnaise Industrielle Pharmaceutique. Active years: 1995-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel Guerrier. Retrieved from https://idiyas.com/inventor/daniel-guerrier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16 

% Patents Active = 37.5

 

Average Co-Inventor Count = 6.0

ph-index = 5

Forward Citations = 65(Granted Patents)


Location History:

  • Sait-Genis-Laval, FR (1997)
  • Saint Genis Laval, FR (1995 - 2012)

Company Filing History:

goldMedal8 out of 3,025 
 
Merck Patent Gmbh
 patents
silverMedal4 out of 1,248 
 
Merck Patent Gesellschaft MIT Beschrankter Haftung
 patents
bronzeMedal3 out of 34 
 
Lipha, Lyonnaise Industrielle Pharmaceutique
 patents
4. 1 out of 121 
 
Merck Patent Gesellschaft
 patents

Years Active: 1995-2012

Loading Chart...
Loading Chart...
Areas of Expertise:
Butenoic Acid Derivatives
Hexenoic Acid Derivatives
Dyslipidaemia Treatment
Pharmaceutical Compositions
Carboxylic Acids
Therapeutic Applications
Diabetes Treatment
Atherosclerosis
Cyclic Compounds
Benzopyrans
Sulfonamides
Pentenoic Acid Derivatives
16 patents (USPTO):Explore Patents
1. 8247448 - Butenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and use for the treatment of dyslipidaemia, atherosclerosis and diabetes (2012-08-21),
2. 8063067 - Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof (2011-11-22),
3. 7820847 - Butenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them and use for the treatment of dyslipidaemia, atherosclerosis and diabetes (2010-10-26),
4. 7678831 - Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof (2010-03-16),
5. 7632846 - Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof (2009-12-15),
6. 7491747 - Butyric acid derivatives (2009-02-17),
7. 7482484 - Carboxylic acids and derivatives for the treatment of and preventing diabetes and dyslipidaemia (2009-01-27),
8. 7465752 - Pentenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof (2008-12-16),
9. 7323458 - Dihydrobenzodiazepins and their use for treating dyslipidemia (2008-01-29),
10. 6596758 - Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process (2003-07-22),
11. 6528538 - Cyclic compounds useful in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharamaceutical compositions and preparation process (2003-03-04),
12. 5652252 - Benzocycloheptenes (1997-07-29),
13. 5602152 - Benzoxepines (1997-02-11),
14. 5489592 - 3,4-dihydro-4-oxo-3-(2-propenyl)-1-phthalazineacetic acids and (1996-02-06),
15. 5476846 - Substituted sulfonamides, process of preparation and medicines (1995-12-19),

**Title: Innovator Spotlight: Daniel Guerrier**

Introduction

Daniel Guerrier is a distinguished inventor based in Saint Genis Laval, France. With a robust portfolio of 16 patents, Guerrier is recognized for his contributions to the fields of pharmaceuticals and biochemistry, particularly in addressing significant health conditions.

Latest Patents

Among his latest patents, Guerrier has developed innovative butenoic acid derivatives and hexenoic acid derivatives. The first patent focuses on butenoic acid derivatives, detailing processes for their preparation, pharmaceutical compositions, and their application in the treatment of dyslipidemia, atherosclerosis, and diabetes. Specifically, this invention involves compounds of a defined structure wherein the residues R, R, R, and R are explicitly described. His work also includes hexenoic acid derivatives, which encompass similar therapeutic applications for managing dyslipidemia, atherosclerosis, and diabetes.

Career Highlights

Guerrier has made significant strides in the pharmaceutical industry, working with reputable organizations such as Merck Patent GmbH and Merck Patent Gesellschaft mit beschränkter Haftung. His experiences in these companies have undoubtedly contributed to his expertise in pharmaceutical innovations and patent applications.

Collaborations

Throughout his career, Daniel Guerrier has collaborated with talented professionals such as Francis Contard and Valérie Guyard-Dangremont. These partnerships have played a crucial role in furthering the development and success of his innovative projects.

Conclusion

Daniel Guerrier exemplifies the spirit of innovation, consistently working to create solutions that tackle critical health challenges. His impressive patent portfolio and contributions to pharmaceutical science highlight the importance of creativity and collaboration in the journey of invention. As he continues to advance his research, the impact of his work is sure to resonate within the medical community and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…